Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
636 |
|
| Actual shortage: | 62 (10%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 557 (88%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
20 (29%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2020-01-20 | 2020-03-04 | 103707 |
| IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2020-01-20 | 2021-09-14 | 103710 |
| IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2020-03-10 | 2020-10-21 | 108338 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108350 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2024-01-30 | 2024-03-17 | 217829 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Actual shortage | 2024-06-06 | 2024-06-06 | 229801 |
| IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Actual shortage | 2024-10-07 | 2024-10-08 | 239494 |
| IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Actual shortage | 2024-11-18 | 2024-11-19 | 243268 |
| LACOSAMIDE | 100MG | TABLET | Resolved | 2023-07-31 | 2023-11-06 | 200437 |
| LACOSAMIDE | 150MG | TABLET | Resolved | 2023-11-22 | 2024-01-30 | 211034 |
| LACOSAMIDE | 150MG | TABLET | Resolved | 2024-05-28 | 2025-04-24 | 228975 |
| LACOSAMIDE | 50MG | TABLET | Resolved | 2024-05-28 | 2025-04-24 | 228984 |
| LACOSAMIDE | 200MG | TABLET | Resolved | 2024-07-03 | 2025-04-24 | 232014 |
| LACOSAMIDE | 100MG | TABLET | Resolved | 2024-07-03 | 2025-04-24 | 232023 |
| LAMOTRIGINE | 100MG | TABLET | Resolved | 2025-04-07 | 2025-05-02 | 254367 |
| LAMOTRIGINE | 150MG | TABLET | Resolved | 2025-04-07 | 2025-05-16 | 254370 |
| LAMOTRIGINE | 150MG | TABLET | Resolved | 2025-10-06 | 2025-11-13 | 268675 |
| LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-11-21 | 2020-12-11 | 67307 |
| LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-02-19 | 2020-12-11 | 76304 |
| LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-07-18 | 2023-09-19 | 198933 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |